Exited position

George Soros’s Zimmer Biomet Holdings Inc (ZBH) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Soros Fund ManagementVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ2 2004Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares130.50KHighest verified quarter-end share count
Quarters reported9Verified quarters with shares above zero
What happened?

Soros Fund Management first reported Zimmer Biomet Holdings Inc in Q2 2004. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Soros Fund Management sold the entire position in Q2 2018, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2018
Sold the entire position−128.00K shares · No shares reported at quarter-end
Q1 2018
Sold 1.9% of the position−2.50K shares · 128.00K shares remained
Filing context

Quarter-end price $109.04 · Estimated holding basis $118.95

Q4 2017
Bought 108.8% more+68.00K shares · 130.50K shares reported after the change
Filing context

Quarter-end price $120.67 · Estimated holding basis $118.95

Q3 2017
New position+62.50K shares · 62.50K shares reported
Filing context

Quarter-end price $117.09 · Estimated holding basis $117.09

Q1 2016
Sold the entire position−4.70K shares · No shares reported at quarter-end
Q4 2015
New position+4.70K shares · 4.70K shares reported
Filing context

Quarter-end price $102.55 · Estimated holding basis $102.55

Portfolio importance

How important was Zimmer Biomet Holdings Inc in Soros Fund Management’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.3%Q1 2018
Last reported rank#93of 200 reported positions
Peak portfolio weight0.4%Q2 2004
Best historical rank#44Q2 2004
At peak importanceQ2 2004
ZBH
0.4%
Largest holding
28.7%
Cross-investor discovery

Who else owns Zimmer Biomet Holdings Inc?

Also reported by 2 other tracked investors in their latest verified filings.

Ray DalioBridgewater Associates, LP
ZBH0.0% of reported portfolio
Joel GreenblattGotham Asset Management
ZBH0.0% of reported portfolio
Explore Zimmer Biomet Holdings Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$98.412026-09-15

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Soros Fund Management LLC’s Form 13F disclosures—not George Soros’s personal brokerage account. George Soros founded the firm; its current CEO and chief investment officer is Dawn Fitzpatrick. Form 13F does not reveal exact trade dates, execution prices or the purpose of an option position.